Advances in the Treatment of Metastatic Prostate Cancer

Jong Chul Park, Mario Eisenberger

Research output: Contribution to journalArticlepeer-review

Abstract

During the past several years, there has been substantial progress in the development of treatments for advanced prostate cancer with the approval of multiple new life-prolonging agents using different mechanisms of action. Such progress was attainable because of advances in our understanding of the biology behind mechanisms of androgen receptor pathway activation, complex tumor-microenvironment interaction of bone metastasis, antitumor immunology, and new oncogenic pathways. Continuous efforts are being made to develop new therapeutics with novel mechanisms of action, define the optimal sequences and/or combinations of current agents, and identify reliable surrogate end points to facilitate new drug development.

Original languageEnglish (US)
Pages (from-to)1719-1733
Number of pages15
JournalMayo Clinic Proceedings
Volume90
Issue number12
DOIs
StatePublished - 2015

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Advances in the Treatment of Metastatic Prostate Cancer'. Together they form a unique fingerprint.

Cite this